PortalPublikationenDevelopment of radiation exposure in patients undergoing pul...

Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage

Standard

Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. / Kleemann, Thomas; Brachmann, Johannes; Lewalter, Thorsten; Andresen, Dietrich; Willems, Stephan; Spitzer, Stefan G; Hoffmann, Ellen; Eckardt, Lars; Hochadel, Matthias; Senges, Jochen; Kuck, Karl-Heinz; Seidl, Karlheinz; Zahn, Ralf.

in: CLIN RES CARDIOL, Jahrgang 105, Nr. 10, 10.2016, S. 858-864.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kleemann, T, Brachmann, J, Lewalter, T, Andresen, D, Willems, S, Spitzer, SG, Hoffmann, E, Eckardt, L, Hochadel, M, Senges, J, Kuck, K-H, Seidl, K & Zahn, R 2016, 'Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage', CLIN RES CARDIOL, Jg. 105, Nr. 10, S. 858-864. https://doi.org/10.1007/s00392-016-0994-9

APA

Kleemann, T., Brachmann, J., Lewalter, T., Andresen, D., Willems, S., Spitzer, S. G., Hoffmann, E., Eckardt, L., Hochadel, M., Senges, J., Kuck, K-H., Seidl, K., & Zahn, R. (2016). Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. CLIN RES CARDIOL, 105(10), 858-864. https://doi.org/10.1007/s00392-016-0994-9

Vancouver

Kleemann T, Brachmann J, Lewalter T, Andresen D, Willems S, Spitzer SG et al. Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. CLIN RES CARDIOL. 2016 Okt;105(10):858-864. https://doi.org/10.1007/s00392-016-0994-9

Bibtex

@article{b4fe5af64cf2474e8a672506fdc3cae2,
title = "Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage",
abstract = "AIM: The aim of this study was to analyze the radiation usage in patients undergoing pulmonary vein isolation (PVI) in Germany and to evaluate the possibility to reduce radiation dose.METHODS AND RESULTS: A total of 6617 patients with atrial fibrillation (AF) from the German ablation registry and the FREEZEplus registry (control group), who underwent first PVI between 2007 and 2014, were analyzed. In the second step, the effect of optimized conventional fluoroscopy and optimized 3D mapping use was evaluated in 526 consecutive patients with AF who underwent first PVI at the Klinikum Ludwigshafen (optimized group) between 2007 and 2014. In the control group, the median dose area product (DAP) for PVI was 34 Gy cm(2), and the median DAP rate was 1.3 Gy cm(2)/min. The DAP decreased from 37 to 28 Gy cm(2), whereas the DAP rate increased from 1.3 to 1.6 Gy cm(2)/min between 2007 and 2014. In the optimized group, optimized radiation application and use of 3D mapping resulted in a continuous decrease in the DAP from 67 to 2 Gy cm(2) and DAP rate from 1.0 to 0.2 Gy cm(2)/min.CONCLUSION: Currently, the median radiation exposure during PVI in Germany is 28 Gy cm(2). Optimized fluoroscopy by simple means can safely reduce the radiation dose to about 2 Gy cm(2) or even lower when using 3D mapping. Before introducing novel expensive technologies for radiation reduction optimizing of the conventional fluoroscopy is mandatory.",
keywords = "Aged, Atrial Fibrillation/diagnostic imaging, Catheter Ablation/adverse effects, Female, Fluoroscopy, Germany, Humans, Male, Middle Aged, Phlebography/adverse effects, Pulmonary Veins/diagnostic imaging, Radiation Dosage, Radiation Exposure/adverse effects, Radiation Injuries/etiology, Radiography, Interventional/adverse effects, Registries, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome",
author = "Thomas Kleemann and Johannes Brachmann and Thorsten Lewalter and Dietrich Andresen and Stephan Willems and Spitzer, {Stefan G} and Ellen Hoffmann and Lars Eckardt and Matthias Hochadel and Jochen Senges and Karl-Heinz Kuck and Karlheinz Seidl and Ralf Zahn",
year = "2016",
month = oct,
doi = "10.1007/s00392-016-0994-9",
language = "English",
volume = "105",
pages = "858--864",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "10",

}

RIS

TY - JOUR

T1 - Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage

AU - Kleemann, Thomas

AU - Brachmann, Johannes

AU - Lewalter, Thorsten

AU - Andresen, Dietrich

AU - Willems, Stephan

AU - Spitzer, Stefan G

AU - Hoffmann, Ellen

AU - Eckardt, Lars

AU - Hochadel, Matthias

AU - Senges, Jochen

AU - Kuck, Karl-Heinz

AU - Seidl, Karlheinz

AU - Zahn, Ralf

PY - 2016/10

Y1 - 2016/10

N2 - AIM: The aim of this study was to analyze the radiation usage in patients undergoing pulmonary vein isolation (PVI) in Germany and to evaluate the possibility to reduce radiation dose.METHODS AND RESULTS: A total of 6617 patients with atrial fibrillation (AF) from the German ablation registry and the FREEZEplus registry (control group), who underwent first PVI between 2007 and 2014, were analyzed. In the second step, the effect of optimized conventional fluoroscopy and optimized 3D mapping use was evaluated in 526 consecutive patients with AF who underwent first PVI at the Klinikum Ludwigshafen (optimized group) between 2007 and 2014. In the control group, the median dose area product (DAP) for PVI was 34 Gy cm(2), and the median DAP rate was 1.3 Gy cm(2)/min. The DAP decreased from 37 to 28 Gy cm(2), whereas the DAP rate increased from 1.3 to 1.6 Gy cm(2)/min between 2007 and 2014. In the optimized group, optimized radiation application and use of 3D mapping resulted in a continuous decrease in the DAP from 67 to 2 Gy cm(2) and DAP rate from 1.0 to 0.2 Gy cm(2)/min.CONCLUSION: Currently, the median radiation exposure during PVI in Germany is 28 Gy cm(2). Optimized fluoroscopy by simple means can safely reduce the radiation dose to about 2 Gy cm(2) or even lower when using 3D mapping. Before introducing novel expensive technologies for radiation reduction optimizing of the conventional fluoroscopy is mandatory.

AB - AIM: The aim of this study was to analyze the radiation usage in patients undergoing pulmonary vein isolation (PVI) in Germany and to evaluate the possibility to reduce radiation dose.METHODS AND RESULTS: A total of 6617 patients with atrial fibrillation (AF) from the German ablation registry and the FREEZEplus registry (control group), who underwent first PVI between 2007 and 2014, were analyzed. In the second step, the effect of optimized conventional fluoroscopy and optimized 3D mapping use was evaluated in 526 consecutive patients with AF who underwent first PVI at the Klinikum Ludwigshafen (optimized group) between 2007 and 2014. In the control group, the median dose area product (DAP) for PVI was 34 Gy cm(2), and the median DAP rate was 1.3 Gy cm(2)/min. The DAP decreased from 37 to 28 Gy cm(2), whereas the DAP rate increased from 1.3 to 1.6 Gy cm(2)/min between 2007 and 2014. In the optimized group, optimized radiation application and use of 3D mapping resulted in a continuous decrease in the DAP from 67 to 2 Gy cm(2) and DAP rate from 1.0 to 0.2 Gy cm(2)/min.CONCLUSION: Currently, the median radiation exposure during PVI in Germany is 28 Gy cm(2). Optimized fluoroscopy by simple means can safely reduce the radiation dose to about 2 Gy cm(2) or even lower when using 3D mapping. Before introducing novel expensive technologies for radiation reduction optimizing of the conventional fluoroscopy is mandatory.

KW - Aged

KW - Atrial Fibrillation/diagnostic imaging

KW - Catheter Ablation/adverse effects

KW - Female

KW - Fluoroscopy

KW - Germany

KW - Humans

KW - Male

KW - Middle Aged

KW - Phlebography/adverse effects

KW - Pulmonary Veins/diagnostic imaging

KW - Radiation Dosage

KW - Radiation Exposure/adverse effects

KW - Radiation Injuries/etiology

KW - Radiography, Interventional/adverse effects

KW - Registries

KW - Risk Assessment

KW - Risk Factors

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1007/s00392-016-0994-9

DO - 10.1007/s00392-016-0994-9

M3 - SCORING: Journal article

C2 - 27142281

VL - 105

SP - 858

EP - 864

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 10

ER -